Contraindications
- None listed in the retrieved insert
Dosing: Adult
- Peripheral neuropathy (adults, oral): 1,500 micrograms/day in 3 divided doses
- Amyotrophic lateral sclerosis (Japan, high-dose injection): 50 mg intramuscularly twice weekly (Rozebalamin; Japan-only indication)
Dosing: Altered kidney function
Mecobalamin (methylcobalamin) is an active vitamin B12 form, cleared mainly by the kidneys. The Japanese tablet insert does not address kidney impairment; a 2024 Japanese regulatory review of high-dose injection found only modest exposure increases with kidney impairment and concluded no dose adjustment is needed, with limited data in severe impairment. It has no US FDA drug label.
Kidney function measure: Japanese sources describe kidney impairment as mild, moderate or severe without dose changes; bands shown on creatinine clearance (CrCl).
Show full dosing details
- CrCl ≥60 mL/min
- Usual oral dose: 1,500 micrograms/day in 3 divided doses (500 micrograms three times daily); reassess if no effect after several months (PMDA insert).
- CrCl 30–59 mL/min
- No dose adjustment. A Japanese regulatory review of high-dose intramuscular mecobalamin (50 mg twice weekly) found AUC about 1.2-fold (mild, n=4) and 1.6-fold (moderate, n=3) versus a single normal subject; there are no PK data in severe impairment. PMDA concluded no dose adjustment is needed. Extrapolated to oral 1,500 micrograms/day (judgment); the oral tablet insert does not address kidney function.
- CrCl 15–29 mL/min
- No dose adjustment. A Japanese regulatory review of high-dose intramuscular mecobalamin (50 mg twice weekly) found AUC about 1.2-fold (mild, n=4) and 1.6-fold (moderate, n=3) versus a single normal subject; there are no PK data in severe impairment. PMDA concluded no dose adjustment is needed. Extrapolated to oral 1,500 micrograms/day (judgment); the oral tablet insert does not address kidney function.
- CrCl <15 mL/min (not on dialysis)
- No dose adjustment. A Japanese regulatory review of high-dose intramuscular mecobalamin (50 mg twice weekly) found AUC about 1.2-fold (mild, n=4) and 1.6-fold (moderate, n=3) versus a single normal subject; there are no PK data in severe impairment. PMDA concluded no dose adjustment is needed. Extrapolated to oral 1,500 micrograms/day (judgment); the oral tablet insert does not address kidney function.
- Hemodialysis (intermittent)
- No dialysis data in the Japanese sources.
- Peritoneal dialysis
- No dialysis data.
- CRRT
- No data.
- Dialyzable? Not stated.
- Monitoring Clinical response in peripheral neuropathy; do not continue for months without benefit (PMDA insert).
Children (kidney dosing)
- eGFR ≥60
- Not established in children; kidney dosing not applicable.
- eGFR 30–59
- Not established in children; kidney dosing not applicable.
- eGFR 15–29
- Not established in children; kidney dosing not applicable.
- eGFR <15 (not on dialysis)
- Not established in children; kidney dosing not applicable.
- Hemodialysis (intermittent)
- Not established in children; kidney dosing not applicable.
- Peritoneal dialysis
- Not established in children; kidney dosing not applicable.
- CRRT
- Not established in children; kidney dosing not applicable.
Pediatric eGFR: bedside Schwartz equation, 0.413 × height (cm) / serum creatinine (mg/dL). Weight-based doses should not exceed the adult maximum.
renalcarematters.com guidance, reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Sources are listed under References. Use with the product's package insert and the patient's current kidney function.
Source: PMDA (Japan) product information (October 2023). This generic has no US FDA label.
Dosing: Pediatric
- Approved ages
- No pediatric trials (PMDA insert).
- Usual dose
- Not established.
Kidney dosing in children: see Dosing: Altered kidney function.
renalcarematters.com, reviewedDosage forms
Philippines
- Solution for injection: 500 mcg/mL
- Film-coated tablet: 1 mg, 1.5 mg, 500 mcg
- Capsule: 500 mcg
- Sugar-coated tablet: 500 mcg
- Chewable tablet: 500 mcg
- Tablet: 500 mcg
Registered products in the Philippines
28 products registered with the Food and Drug Administration (FDA) Philippines list Mecobalamin as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products28
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
AdnervMecobalamin | 500 mcg Chewable TabletAlu/Alu Blister Pack x 10's (Box of 60's) | RxVAT-exempt | Incepta Pharmaceuticals, Ltd.Bangladesh | Sahar International Trading, Inc. | DR-XY44776 | Aug 26, 2028 | |
GeocobalaminMecobalamin | 500 mcg Sugar-Coated TabletAluminum/PVC Blister Pack x 10's (Box of 20's) | RxVAT-exempt | Geofman PharmaceuticalsPakistan | Sahar International Trading Inc. | DRP-7771 | Mar 9, 2029 | |
GeocobalaminMecobalamin | 500 mcg/mL Solution For Injection (IM/IV)1 mL Amber Glass Ampoule Box of 10's | RxVAT-exempt | Geofman PharmaceuticalsPakistan | Sahar International Trading, Inc. | DRP-7803 | Dec 29, 2029 | |
IncobalMecobalamin | 500 mcg/mL Solution For Injection (IM/IV)USP Type I Amber Glass Ampoule x 1 mL (Box of 10's) | RxVAT-exempt | Indus Pharma (Pvt.) Ltd.Pakistan | One Dexcel Pharma Inc. | DRP-13399 | Feb 15, 2028 | |
KalmecoMecobalamin | 500 mcg CapsuleAluminum Foil Strip x 10's (Box of 100's) | RxVAT-exempt | PT. Kalbe Farma TbkIndonesia | Globo Asiatico Enterprises, Inc. | DR-XY49140 | Jul 31, 2029 | |
KeercominMecobalamin | 500 mcg/mL Solution for Injection (IM/IV)USP Type I Amber Glass Ampoule x 1 mL (Box of 10 ampoules in transparent plastic tray) | RxVAT-exempt | Cooper Pharma LimitedIndia | L'Keeran EnterprisesImporter: Ambica International Corporation | DRP-10650-01 | Aug 6, 2037 | |
MaxibalMecobalamin | 500 mcg/mL Solution for Injection (I.M./I.V.)Type I Amber Glass Ampoule in PVC Tray x 1 mL (Box of 10's) | RxVAT-exempt | Maxitech Pharma (Pvt) Ltd.Pakistan | Access Point International Trading Inc.Importer: Accesspoint International Trading, Inc. | DRP-15397 | Jul 2, 2029 | |
ME12Mecobalamin | 500 mcg/mL Solution for Injection (IM/IV)Type I Amber Color Glass Ampoule x 1 mL (net content) Box of 10’S | RxVAT-exempt | CSPC Ouyi Pharmaceutical Co. Ltd.China | Medhart Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-8612 | Aug 13, 2029 | |
Mebaal-1500Mecobalamin | 1.5 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Windlas Biotech Limited (Plant-IV)India | Metro Drug, Inc.Trader: Mega Lifesciences (Australia) Pty. Ltd. | DR-XY38969 | Mar 19, 2030 | |
Mebaal-500Mecobalamin | 500 mcg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Windlas Biotech Limited (Plant-IV)India | Metro Drug, Inc.Importer: Mega Lifesciences Limited Inc.Trader: Mega Lifesciences Limited Inc. (Australia) Pty. Ldt. | DR-XY37578 | Mar 19, 2030 | |
MecobalzoneMecobalamin | 500 mcg Sugar-Coated TabletAluminum/PVC Blister Pack x 10's (Box of 20's) | RxVAT-exempt | Geofman PharmaceuticalsPakistan | Amson PharmaceuticalsImporter: Sahar International Trading, Inc. | DRP-7771-01 | Mar 9, 2029 | |
MeconervMecobalamin | 1 mg Film-Coated TabletAlu-amber PVC/PVDC blister pack x 10's (Box of 3 blister packs x 10 tablets) | RxVAT-exempt | Micro Labs LimitedIndia | Brown & Burk Phils., Inc. | DR-XY48322 | Aug 30, 2027 | |
MeconervMecobalamin | 1.5 mg Film-Coated TabletAlu-Amber PVC/PVDC Blister Pack x 10's (Box of 3 blister packs x 10 tablets) | RxVAT-exempt | Micro Labs LimitedIndia | Brown & Burk Phils., Inc. | DR-XY48321 | Aug 30, 2027 | |
MeconeuroMecobalamin | 500 mcg CapsulePVC/PVDC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | — | Prosweal Healthcare Inc. | DR-XY45800 | Mar 3, 2027 | |
MeconeuroMecobalamin | 500mcg/mL Solution for Injection (IM/IV)1ml USP Type I amber glass ampoule mounted in PVC tray x 5 ampoules Box of 10 ampoules | RxVAT-exempt | PT. Novell Pharmaceutical LaboratoriesIndonesia | Prosweal Healthcare Inc. | DRP-7352 | Sep 29, 2027 | |
Mefredzil-1500Mecobalamin | 500 mcg/mL Solution for Injection (IM/IV)USP Type I Amber Glass Ampoule x 3mL (Box of 10 ampoules in transparent plastic tray) | RxVAT-exempt | Cooper Pharma LimitedIndia | Ambica International Corporation | DRP-10649 | May 20, 2027 | |
Mefredzil-500Mecobalamin | 500 mcg/mL Solution for Injection (IM/IV)USP Type I Amber Glass Ampoule x 1 mL (Box of 10 ampoules in transparent plastic tray) | RxVAT-exempt | Cooper Pharma LimitedIndia | Ambica International Corporation | DRP-10650 | Nov 11, 2030 | |
MethycobalMecobalamin | 500 mcg TabletAlu/Red PVC Blister Pack x l0's (10 Blister Packs containing 100 tablets overwrapped in Aluminum Sachet per Box) | RxVAT-exempt | Interphil Laboratories, Inc.Philippines | Zuellig Pharma Corp.Trader: Hi-Eisai Pharmaceutical Inc. | DR-XY14117 | Nov 18, 2027 | |
MethycobalMecobalamin | 500mcg/mL Solution for Injection (IM/IV)Amber Glass Ampoule x 1 mL (Box of 10) | RxVAT-exempt | Nipro Pharma Corporation (Ise Plant)Japan | Zuellig Pharma CorporationImporter: Hi-Eisai Pharmaceutical Inc. | DR-XY7408 | Apr 11, 2032 | |
MineMecobalamin | 500 mcg/mL Solution for Injection (I.M./I.V.)USP Type I amber glass ampoule x 1 mL (net content) (Box of 10's) | RxVAT-exempt | Bio-Labs (Pvt) Ltd.Pakistan | Nueva Sunshine Phils., Inc. | DRP-8457 | Oct 10, 2029 | |
NerveeminMecobalamin | 500 mcg/mL Solution for Injection (IM/IV)1 mL Amber Glass Ampoule (Box of 10's) | RxVAT-exempt | Geofman PharmaceuticalsPakistan | Amson Pharmaceuticals | DRP-7803-02 | Dec 29, 2029 | |
NeurometMecobalamin | 500 mcg CapsuleAluminum PVC blister pack x 10’s Box of 100’s | RxVAT-exempt | SAMCHUDANG PHARM. CO., LTDRepublic of Korea | D&G PHARMAImporter: UNIMEX, INC. | DR-XY36897 | Nov 9, 2027 | |
NoneMecobalamin | 500 mcg/ mL Solution for Injection (IM/IV)USP Type I amber glass ampoule x 1 mL (net content) in Alu/PVC blister tray (Box of 4's) | RxVAT-exempt | Mankind Pharma Limited (Unit-1)India | I.E. Medica Inc | DRP-8506 | Oct 22, 2029 | |
NoneMecobalamin | 500 mcg/mL Solution for Injection (IM/IV)Amber glass ampoule x 1 mL (Box of 5 ampoules in plastic tray) | RxVAT-exempt | Zee Laboratories LimitedHimachal Pradesh India | Eon Pharmatek Inc. | DR-XY48364 | Sep 28, 2032 | |
NurokindMecobalamin | 500 mcg/ml Solution for Injection (IM/IV)USP Type I Amber Glass Ampoule x 1 mL (net content) in Alu/PVC Blister Tray (Box of 4's) | RxVAT-exempt | Mankind Pharma Limited (Unit-1)India | I.E. Medica, Inc. | DRP-8505 | Oct 22, 2029 | |
PhilaminMecobalamin | 500 mcg/mL Solution for Injection (IM/IV)Type I Amber Color Glass Ampoule x 1 mL (net content) Box of 10's | RxVAT-exempt | CSPC Ouyi Pharmaceutical Co., LtdChina | PhilRx Pharma Inc.Importer: AMB HK ENTERPRISES INC. | DRP-8612-01 | Aug 13, 2029 | |
ZecobalMecobalamin | 500 mcg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30’s) | RxVAT-exempt | The Schazoo Pharmaceutical Laboratories (Pvt) LtdPakistan | ZUNECA INCORPORATED | DR-XY43935 | Dec 2, 2029 | |
(no brand name)Mecobalamin | 500 mcg/mL Solution for Injection (IM/IV)Type I Amber colored Glass Ampoule x 1 mL (Box of 10's) | RxVAT-exempt | Ta Fong Pharmaceutical Co., Ltd.Taiwan | Kwanstar Pharma DistributorTrader: Kwanstar Co., Ltd. | DRP-13386 | Feb 9, 2028 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Adverse reactions
Common
- Anorexia, nausea, vomiting, diarrhea (frequency unknown)
- Rash
Serious
- None specific listed in the retrieved insert
Monitoring parameters
- Clinical response in peripheral neuropathy; do not continue for months without benefit (PMDA insert). Kidney
- Clinical response
Pharmacokinetics
Key PK parameters
| Time to peak | IM 50 mg: about 1 to 2 hours |
|---|---|
| Half-life | IM 50 mg: about 2.8 to 3.4 hours |
| Half-life in kidney failure (ESKD) kidney | AUC 6.78 (normal, n=1), 8.29 (mild) and 10.60 µg·h/mL (moderate) after IM 50 mg |
| Renal excretion kidney | Mainly renal (animal data: about 92% to 99% in urine) |
| Dialyzability kidney | Not stated |
Formulary and pricing (Philippines)
Government price references
| Preparation | Price (PHP) | Unit | Type |
|---|---|---|---|
| Mecobalamin 500 mcg Tablet | ₱10.00–₱13.67Reference ₱11.00 | per tablet | DPRI procurement range |
| Mecobalamin 500 mcg/mL, 1 mL Ampule | ₱98.00–₱186.00Reference ₱173.00 | per ampule | DPRI procurement range |
Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)
These are government procurement and reimbursement references, not retail prices. Sources:
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf, as of September 17, 2021
Formulary and coverage
| Philippine National Formulary | Listed as Mecobalamin |
| PNF listing | Oral: 500 microgram tablet |
| PNF listing | Inj.: 500 micrograms/mL, 1 mL ampul (IM, IV) |
| PhilHealth GAMOT | No |
Sources:
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf, as of November 2, 2022
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Pharmaceuticals and Medical Devices Agency (Japan). Mecobalamin tablets 500 µg "TCK" package insert; Rozebalamin review report [PMDA (Japan) product information, October 2023; no US FDA label]. https://www.pmda.go.jp/PmdaSearch/bookSearch/01/04987124904116
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf
- Tatsumi Chemical Co., Ltd. (2023). Mecobalamin tablets 500 µg "TCK" [Japanese package insert; revised October 2023]. Pharmaceuticals and Medical Devices Agency (PMDA), Japan. https://www.pmda.go.jp/PmdaSearch/bookSearch/01/04987124904116
- Pharmaceuticals and Medical Devices Agency. (2024). Review report: Rozebalamin for injection 25 mg (mecobalamin), Eisai Co., Ltd. [Report dated August 8, 2024]. https://www.pmda.go.jp/files/000277177.pdf
renalcarematters.com content: Kidney and pediatric dosing: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Dosing, interaction, adverse-effect and monitoring summary: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026.
Last updated: .